Ratings
0
Nobody has rated this yet. Be the first!
Works
24
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition
RAD51C is a susceptibility gene for ovarian cancer
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer
Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D
Recessively inherited right atrial isomerism caused by mutations in growth/differentiation factor 1 (GDF1)
